Clinical trial
Comparison of the Safety and Efficacy of PreserFlo MicroShunt and XEN Stent Alone Versus With Amniotic Membrane in Glaucoma Surgery
NCT07143708 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Safety and Efficacy of PreserFlo MicroShunt and XEN Stent Alone Versus With Amniotic Membrane in Glaucoma Surgery
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 156 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.